Latest News from ASCO in Action

Latest News from ASCO in Action

October 1, 2014

The National Cancer Institute announced the launch of the Exceptional Responders Initiative, a study that will investigate the molecular factors associated with exceptional responses to treatment therapies in cancer patients.

October 1, 2014

The National Cancer Institute's RAS Program has launched a new website, a tool for researchers working to better understand the role of RAS mutations in cancer.

October 1, 2014

The American Medical Association has provided the following information to healthcare providers regarding the recent Drug Enforcement Administration final rule rescheduling hydrocodone combination products (HCPs) into Controlled Substance Schedule II, effective Oct. 6, 2014.

ASCO's ACT Network

ASCO's ACT Network

ALERT CONGRESS TODAY! Use ASCO's ACT Network to contact your elected officials on important policy issues impacting cancer care. 

ASCO Issue Backgrounders

ASCO Issue Backgrounders

ASCO offers issue backgrounders to help provide an overview of the major policy issues that impact patients with cancer and the physicians who care for them. The issue backgrounders cover topics such as reimbursement, health equity, cancer research funding, and more.

Click here to read the backgrounds and help develop your understanding of cancer policy issues.

NIH Funding Educational Series

NIH Funding Educational Series

ASCO explores the decade-long decline in federal funding for cancer research – and why this decline must be reversed. Read more here.